Pregnancy and the incidence, diagnosing and therapy of Graves' disease

European Journal of Endocrinology

Volumn 175, Issue 5, 2016, Pages R219-R230

  Laurberg, Peter ^a,b   Andersen, Stine Linding ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIMAZOLE; CHORIONIC GONADOTROPIN; COLESTYRAMINE; IODINE; PERCHLORATE; PROPYLTHIOURACIL; THIAMAZOLE; THYROTROPIN; THYROXINE BINDING GLOBULIN; ANTITHYROID AGENT;

ABDOMINAL WALL DEFECT; BLOOD LEVEL; DIFFERENTIAL DIAGNOSIS; FEEDBACK SYSTEM; FIRST TRIMESTER PREGNANCY; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INCIDENCE; NECK MALFORMATION; PATIENT COUNSELING; PHARMACEUTICAL CARE; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; REFERENCE VALUE; REVIEW; SKIN DEFECT; TERATOGENICITY; THYROID FUNCTION; THYROID FUNCTION TEST; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL; URINARY TRACT MALFORMATION; FEMALE; PREGNANCY COMPLICATIONS; TREATMENT OUTCOME;

ANTITHYROID AGENTS; FEMALE; GRAVES DISEASE; HUMANS; INCIDENCE; PREGNANCY; PREGNANCY COMPLICATIONS; TREATMENT OUTCOME;

EID: 84991396788     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-16-0410     Document Type: Review

References (98)

1. Gudernatsch JF Feeding experiments in tadpoles: I. The influence of specific organs given as food on growth and differentiation. A contribution to the knowledge of organs with internal secretion. Wilhelm Roux' Archiv fur Entwicklungsmechanik der Organismen 1912 35 457-483. (doi:10.1007/BF02277051)
2. Bernal J. Thyroid hormones and brain development. Vitamins and Hormones 2005 71 95-122. (doi:10.1016/S0083-6729(05)71004-9)
3. Rovet JF The role of thyroid hormones for brain development and cognitive function. Endocrine Development 2014 26 26-43. (doi:10.1159/000363153)
4. Andersen SL, Olsen J, Wu CS & Laurberg P. Spontaneous abortion, stillbirth and hyperthyroidism: a Danish population-based study. European Thyroid Journal 2014 3 164-172. (doi:10.1159/000365101)
5. Andersen SL, Olsen J & Laurberg P. Foetal programming by maternal thyroid disease. Clinical Endocrinology 2015 83 751-758. (doi:10.1111/cen.12744)
6. Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, Nixon A, Pearce EN, Soldin OP, Sullivan S et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011 21 1081-1125.
7. De Groot L, Abalovich M, Alexander EK, Amino N, Barbour L, Cobin RH, Eastman CJ, Lazarus JH, Luton D, Mandel SJ et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2012 97 2543-2565.
8. Laurberg P, Cerqueira C, Ovesen L, Rasmussen LB, Perrild H, Andersen S, Pedersen IB & Carlé A. Iodine intake as a determinant of thyroid disorders in populations. Best Practice & Research. Clinical Endocrinology & Metabolism 2010 24 13-27. (doi:10.1016/j.beem.2009.08.013)
9. Laurberg P, Pedersen KM, Vestergaard H & Sigurdsson G. High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area vs. high incidence of Graves' disease in the young in a high iodine intake area: comparative surveys of thyrotoxicosis epidemiology in East-Jutland Denmark and Iceland. Journal of Internal Medicine 1991 229 415-420. (doi:10.1111/joim.1991.229.issue-5)
10. Carlé A, Pedersen IB, Knudsen N, Perrild H, Ovesen L, Rasmussen LB & Laurberg P. Epidemiology of subtypes of hyperthyroidism in Denmark: a population-based study. European Journal of Endocrinology 2011 164 801-809. (doi:10.1530/EJE-10-1155)
11. Ngo ST, Steyn FJ & McCombe PA. Gender differences in autoimmune disease. Frontiers in Neuroendocrinology 2014 35 347-369. (doi:10.1016/j.yfrne.2014.04.004)
12. Andersen SL, Olsen J, Carlé A & Laurberg P. Hyperthyroidism incidence fluctuates widely in and around pregnancy and is at variance with some other autoimmune diseases: a Danish populationbased study. Journal of Clinical Endocrinology and Metabolism 2015 100 1164-1171. (doi:10.1210/jc.2014-3588)
13. Amino N, Tanizawa O, Mori H, Iwatani Y, Yamada T, Kurachi K, Kumahara Y & Miyai K. Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease. Journal of Clinical Endocrinology and Metabolism 1982 55 108-112. (doi:10.1210/jcem-55-1-108)
14. Momotani N, Hisaoka T, Noh J, Ishikawa N & Ito K. Effects of iodine on thyroid status of fetus versus mother in treatment of Graves' disease complicated by pregnancy. Journal of Clinical Endocrinology and Metabolism 1992 75 738-744.
15. Momotani N, Noh JY, Ishikawa N & Ito K. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism. Journal of Clinical Endocrinology and Metabolism 1997 82 3633-3636.
16. Jansson R, Dahlberg PA & Karlsson FA. Postpartum thyroiditis. Bailliere's Clinical Endocrinology and Metabolism 1988 2 619-635. (doi:10.1016/S0950-351X(88)80056-9)
17. Andersen SL, Carlé A, Olsen J & Laurberg P. Comparison of hypothyroidism and hyperthyroidism incidences during pregnancy and postpartum: a Danish population-based study. Thyroid 2015 25 A82.
18. De Vito P, Incerpi S, Pedersen JZ, Luly P, Davis FB & Davis PJ. Thyroid hormones as modulators of immune activities at the cellular level. Thyroid 2011 21 879-890. (doi:10.1089/thy.2010.0429)
19. Laurberg P. Remission of Graves' disease during anti-thyroid drug therapy. Time to reconsider the mechanism? European Journal of Endocrinology 2006 155 783-786. (doi:10.1530/eje.1.02295)
20. Krassas GE, Poppe K & Glinoer D. Thyroid function and human reproductive health. Endocrine Reviews 2010 31 702-755. (doi:10.1210/er.2009-0041)
21. Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, Laurberg P, McDougall IR, Montori VM, Rivkees SA et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American thyroid association and American association of clinical endocrinologists. Thyroid 2011 21 593-646. (doi:10.1089/thy.2010.0417)
22. Spencer CA Clinical utility and cost-effectiveness of sensitive thyrotropin assays in ambulatory and hospitalized patients. Mayo Clinic Proceedings 1988 63 1214-1222.
23. Galton VA, Martinez E, Hernandez A, St Germain EA, Bates JM & St Germain DL. Pregnant rat uterus expresses high levels of the type 3 iodothyronine deiodinase. Journal of Clinical Investigation 1999 103 979-987. (doi:10.1172/JCI6073)
24. Huang SA, Dorfman DM, Genest DR, Salvatore D & Larsen PR. Type 3 iodothyronine deiodinase is highly expressed in the human uteroplacental unit and in fetal epithelium. Journal of Clinical Endocrinology and Metabolism 2003 88 1384-1388. (doi:10.1210/jc.2002-021291)
25. Weeke J, Dybkjaer L, Granlie K, Eskjaer Jensen S, Kjaerulff E, Laurberg P & Magnusson B. A longitudinal study of serum TSH, and total and free iodothyronines during normal pregnancy. Acta Endocrinologica 1982 101 531-537.
26. Laurberg P, Andersen SL, Pedersen IB, Andersen S & Carlé A. Screening for overt thyroid disease in early pregnancy may be preferable to searching for small aberrations in thyroid function tests. Clinical Endocrinology 2013 79 297-304. (doi:10.1111/cen.2013.79.issue-3)
27. Mortimer RH, Galligan JP, Cannell GR, Addison RS & Roberts MS. Maternal to fetal thyroxine transmission in the human term placenta is limited by INNer ring deiodination. Journal of Clinical Endocrinology and Metabolism 1996 81 2247-2249.
28. Huang SA, Tu HM, Harney JW, Venihaki M, Butte AJ, Kozakewich HP, Fishman SJ & Larsen PR. Severe hypothyroidism caused by type iodothyronine deiodinase in infantile hemangiomas. New England Journal of Medicine 2000 343 185-189. (doi:10.1056/NEJM200007203430305)
29. Alexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA & Larsen PR. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. New England Journal of Medicine 2004 351 241-249. (doi:10.1056/NEJMoa040079)
30. Hershman JM Physiological and pathological aspects of the effect of human chorionic gonadotropin on the thyroid. Best Practice & Research. Clinical Endocrinology & Metabolism 2004 18 249-265. (doi:10.1016/j.beem.2004.03.010)
31. Glinoer D, de Nayer P, Bourdoux P, Lemone M, Robyn C, van Steirteghem A, Kinthaert J & Lejeune B. Regulation of maternal thyroid during pregnancy. Journal of Clinical Endocrinology and Metabolism 1990 71 276-287. (doi:10.1210/jcem-71-2-276)
32. Grun JP, Meuris S, De Nayer P & Glinoer D. The thyrotrophic role of human chorionic gonadotrophin (hCG) in the early stages of twin (versus single) pregnancies. Clinical Endocrinology 1997 46 719-725. (doi:10.1046/j.1365-2265.1997.2011011.x)
33. Dashe JS, Casey BM, Wells CE, McIntire DD, Byrd EW, Leveno KJ & Cunningham FG. Thyroid-stimulating hormone in singleton and twin pregnancy: importance of gestational age-specific reference ranges. Obstetrics and Gynecology 2005 106 753-757. (doi:10.1097/01. AOG.0000175836.41390.73)
34. Männistö T, Surcel HM, Ruokonen A, Vaarasmaki M, Pouta A, Bloigu A, Jarvelin MR, Hartikainen AL & Suvanto E. Early pregnancy reference intervals of thyroid hormone concentrations in a thyroid antibody-negative pregnant population. Thyroid 2011 21 291-298. (doi:10.1089/thy.2010.0337)
35. Li C, Shan Z, Mao J, Wang W, Xie X, Zhou W, Li C, Xu B, Bi L, Meng T et al. Assessment of thyroid function during first-trimester pregnancy: what is the rational upper limit of serum TSH during the first trimester in Chinese pregnant women? Journal of Clinical Endocrinology and Metabolism 2014 99 73-79. (doi:10.1210/jc.2013-1674)
36. Laurberg P, Andersen SL, Hindersson P, Nohr EA & Olsen J. Dynamics and predictors of serum TSH and fT4 reflerence limits in early pregnancy. A study within the Danish National Birth Cohort. Journal of Clinical Endocrinology and Metabolism 2016 101 2484-2492. (doi:10.1210/jc.2016-1387)
37. Soldin OP, Tractenberg RE, Hollowell JG, Jonklaas J, Janicic N & Soldin SJ. Trimester-specific changes in maternal thyroid hormone, thyrotropin, and thyroglobulin concentrations during gestation: trends and associations across trimesters in iodine sufficiency. Thyroid 2004 14 1084-1090.
38. Stockigt J. Assessment of thyroid function: towards an integrated laboratory - clinical approach. Clinical Biochemistry Reviews 2003 24 109-122.
39. Bliddal S, Feldt-Rasmussen U, Boas M, Faber J, Juul A, Larsen T & Precht DH. Gestational age-specific reference ranges from different laboratories misclassify pregnant women's thyroid status: comparison of two longitudinal prospective cohort studies. European Journal of Endocrinology 2013 170 329-339. (doi:10.1530/EJE-13-0672)
40. Lee RH, Spencer CA, Mestman JH, Miller EA, Petrovic I, Braverman LE & Goodwin TM. Free T4 immunoassays are flawed during pregnancy. American Journal of Obstetrics and Gynecology 2009 200 260.e1-260.e6. (doi:10.1016/j.ajog.2008.10.042)
41. Skjöldebrand L, Brundin J, Carlstrom A & Pettersson T. Thyroid associated components in serum during normal pregnancy. Acta Endocrinologica 1982 100 504-511.
42. Ross HA, Exalto N, Kloppenborg PW & Benraad TJ. Thyroid hormone binding in early pregnancy and the risk of spontaneous abortion. European Journal of Obstetrics, Gynecology, and Reproductive Biology 1989 32 129-136. (doi:10.1016/0028-2243(89)90194-9)
43. Casey BM, Dashe JS, Wells CE, McIntire DD, Leveno KJ & Cunningham FG. Subclinical hyperthyroidism and pregnancy outcomes. Obstetrics and Gynecology 2006 107 337-341. (doi:10.1097/01.AOG.0000197991.64246.9a)
44. Laurberg P, Nygaard B, Andersen S, Carlé A, Karmisholt J, Krejbjerg A, Pedersen IB & Andersen SL. Association between TSH-receptor autoimmunity, hyperthyroidism, goitre, and orbitopathy in 208 patients included in the Remission induction and sustenance in Graves' disease study. Journal of Thyroid Research 2014 2014 165487. (doi:10.1155/2014/165487)
45. Pedersen IB, Knudsen N, Perrild H, Ovesen L & Laurberg P. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays. Clinical Endocrinology 2001 55 381-390. (doi:10.1046/j.1365-2265.2001.01347.x)
46. Ashoor G, Muto O, Poon LC, Muhaisen M & Nicolaides KH. Maternal thyroid function at gestational weeks 11-13 in twin pregnancies. Thyroid 2013 23 1165-71. (doi:10.1089/thy.2012.0537)
47. Mestman JH Hyperthyroidism in pregnancy. Current Opinion in Endocrinology, Diabetes, and Obesity 2012 19 394-401. (doi:10.1097/MED.0b013e328357f3d5)
48. Cooper DS & Laurberg P. Hyperthyroidism in pregnancy. Lancet. Diabetes & Endocrinology 2013 1 238-249. (doi:10.1016/S22138587(13)70086-X)
49. Rivkees SA & Szarfman A. Dissimilar hepatotoxicity profles of propylthiouracil and methimazole in children. Journal of Clinical Endocrinology and Metabolism 2010 95 3260-3267. (doi:10.1210/jc.2009-2546)
50. Bahn RS, Burch HS, Cooper DS, Garber JR, Greenlee CM, Klein IL, Laurberg P, McDougall IR, Rivkees SA, Ross D et al. The role of propylthiouracil in the management of Graves' disease in adults: report of a meeting jointly sponsored by the American thyroid association and the food and drug administration. Thyroid 2009 19 673-674.
51. Milham SJ & Elledge W. Maternal methimazole and congenital defects in children. Teratology 1972 5 125-126. (doi:10.1002/(ISSN)1096-9926)
52. Clementi M, Di Gianantonio E, Pelo E, Mammi I, Basile RT & Tenconi R. Methimazole embryopathy: delineation of the phenotype. American Journal of Medical Genetics 1999 83 43-46. (doi:10.1002/(ISSN)1096-8628)
53. Foulds N, Walpole I, Elmslie F & Mansour S. Carbimazole embryopathy: an emerging phenotype. American Journal of Medical Genetics. Part A 2005 132A 130-135. (doi:10.1002/(ISSN)1552-4833)
54. Hackmon R, Blichowski M & Koren G. The safety of methimazole and propylthiouracil in pregnancy: a systematic review. Journal of Obstetrics and Gynaecology Canada 2012 34 1077-1086.
55. Yoshihara A, Noh J, Yamaguchi T, Ohye H, Sato S, Sekiya K, Kosuga Y, Suzuki M, Matsumoto M, Kunii Y et al. Treatment of Graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation. Journal of Clinical Endocrinology and Metabolism 2012 97 2396-2403.
56. Yoshihara A, Noh JY, Watanabe N, Mukasa K, Ohye H, Suzuki M, Matsumoto M, Kunii Y, Suzuki N, Kameda T et al. Substituting potassium iodide for methimazole as the treatment for Graves' disease during the first trimester may reduce the incidence of congenital anomalies: a retrospective study at a single medical institution in Japan. Thyroid 2015 25 1155-1161. (doi:10.1210/jc.2011-2860)
57. Andersen SL, Olsen J, Wu CS & Laurberg P. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study. Journal of Clinical Endocrinology and Metabolism 2013 98 4373-4381. (doi:10.1210/jc.2013-2831)
58. Andersen SL & Laurberg P. Antithyroid drugs and congenital heart defects: ventricular septal defect is part of the methimazole/carbimazole embryopathy. European Journal of Endocrinology 2014 171 C1-C3. (doi:10.1530/EJE-14-0135)
59. Vargesson N. Thalidomide-induced teratogenesis: history and mechanisms. Birth Defects Research. Part C, Embryo Today: Reviews 2015 105 140-156. (doi:10.1002/bdrc.21096)
60. Andersen SL, Olsen J, Wu CS & Laurberg P. Severity of birth defects after propylthiouracil exposure in early pregnancy. Thyroid 2014 24 1533-1540. (doi:10.1089/thy.2014.0150)
61. Chen CH, Xirasagar S, Lin CC, Wang LH, Kou YR & Lin HC. Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study. BJOG 2011 118 1365-1373. (doi:10.1111/j.1471-0528.2011.03019.x)
62. Korelitz JJ, McNally DL, Masters MN, Li SX, Xu Y & Rivkees SA. Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States. Thyroid 2013 23 758-765. (doi:10.1089/thy.2012.0488)
63. Lo JC, Rivkees S, Chandra M, Gonzalez JR, Korelitz JJ & Kuzniewicz MW. Gestational thyrotoxicosis, antithyroid drug use and neonatal outcomes within an integrated healthcare helivery system. Thyroid 2015 25 698-705. (doi:10.1089/thy.2014.0434)
64. Gianetti E, Russo L, Orlandi F, Chiovato L, Giusti M, Benvenga S, Moleti M, Vermiglio F, Macchia PE, Vitale M et al. Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy. Journal of Endocrinological Investigation 2015 38 977-985. (doi:10.1007/s40618-015-0281-z)
65. Laurberg P & Andersen SL. Antithyroid drug use in pregnancy and birth defects: why some studies find clear associations, and some studies report none. Thyroid 2015 25 1185-1190. (doi:10.1089/thy.2015.0182)
66. Moore KL, Persaud TVN & Torchia MG. Human birth defects. In The Developing Human: Clinically Oriented Embryology, edn 9, pp 471-501. Philadelphia, PA, USA: Saunders/Elsevier, 2013.
67. Davis LE, Lucas MJ, Hankins GD, Roark ML & Cunningham FG. Thyrotoxicosis complicating pregnancy. American Journal of Obstetrics and Gynecology 1989 160 63-70. (doi:10.1016/0002-9378(89)90088-4)
68. Millar LK, Wing DA, Leung AS, Koonings PP, Montoro MN & Mestman JH. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstetrics and Gynecology 1994 84 946-949.
69. Hallengren B, Lantz M, Andreasson B & Grennert L. Pregnant women on thyroxine substitution are often dysregulated in early pregnancy. Thyroid 2009 19 391-394. (doi:10.1089/thy.2008.0206)
70. Laurberg P, Wallin G, Tallstedt L, Abraham-Nordling M, Lundell G & Torring O. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. European Journal of Endocrinology 2008 158 69-75. (doi:10.1530/EJE-07-0450)
71. Shiber S, Stiebel-Kalish H, Shimon I, Grossman A & Robenshtok E. Glucocorticoid regimens for prevention of Graves' ophthalmopathy progression following radioiodine treatment: systematic review and meta-analysis. Thyroid 2014 24 1515-1523. (doi:10.1089/thy.2014.0218)
72. Laurberg P & Andersen SL. Graves'-Basedow disease in pregnancy. New trends in the management and guidance to reduce the risk of birth defects caused by antithyroid drugs. Nuklearmedizin 2015 54 106-111.
73. Cooper DS & Rivkees SA. Putting propylthiouracil in perspective. Journal of Clinical Endocrinology and Metabolism 2009 94 1881-1882. (doi:10.1210/jc.2009-0850)
74. Andersen SL, Olsen J & Laurberg P. Antithyroid drug side effects in the population and in pregnancy. Journal of Clinical Endocrinology and Metabolism 2016 101 1606-1614. (doi:10.1210/jc.2015-4274)
75. Laurberg P, Krejbjerg A & Andersen SL. Relapse following antithyroid drug therapy for Graves' hyperthyroidism. Current Opinion in Endocrinology, Diabetes, and Obesity 2014 21 415-421. (doi:10.1097/MED.0000000000000088)
76. Laurberg P, Vestergaard H, Nielsen S, Christensen SE, Seefeldt T, Helleberg K & Pedersen KM. Sources of circulating 3,5,3'-triiodothyronine in hyperthyroidism estimated after blocking of type 1 and type 2 iodothyronine deiodinases. Journal of Clinical Endocrinology and Metabolism 2007 92 2149-2156. (doi:10.1210/jc.2007-0178)
77. Nicholas WC, Fischer RG, Stevenson RA & Bass JD. Single daily dose of methimazole compared to every 8 hours propylthiouracil in the treatment of hyperthyroidism. Southern Medical Journal 1995 88 973-976. (doi:10.1097/00007611-199509000-00018)
78. Kallner G, Vitols S & Ljunggren JG. Comparison of standardized initial doses of two antithyroid drugs in the treatment of Graves' disease. Journal of Internal Medicine 1996 239 525-529. (doi:10.1046/j.1365-2796.1996.489827000.x)
79. Nakamura H, Noh JY, Itoh K, Fukata S, Miyauchi A & Hamada N. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease. Journal of Clinical Endocrinology and Metabolism 2007 92 2157-2162.
80. Means JH The Thyroid and Its Diseases, edn 2. Philadelphia, PA, USA: J. B. Lippincott Company, 1948.
81. Kondrackiene J, Beuers U & Kupcinskas L. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. Gastroenterology 2005 129 894-901. (doi:10.1053/j.gastro.2005.06.019)
82. Gurung V, Middleton P, Milan SJ, Hague W & Thornton JG. Interventions for treating cholestasis in pregnancy. Cochrane Database of Systematic Reviews 2013 6 CD000493. (doi:10.1002/14651858. CD000493.pub2)
83. Solomon BL, Wartofsky L & Burman KD. Adjunctive cholestyramine therapy for thyrotoxicosis. Clinical Endocrinology 1993 38 39-43. (doi:10.1111/j.1365-2265.1993.tb00970.x)
84. Mercado M, Mendoza-Zubieta V, Bautista-Osorio R & Espinoza-de los Monteros AL. Treatment of hyperthyroidism with a combination of methimazole and cholestyramine. Journal of Clinical Endocrinology and Metabolism 1996 81 3191-3193.
85. Tsai WC, Pei D, Wang TF, Wu DA, Li JC, Wei CL, Lee CH, Chen SP & Kuo SW. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism. Clinical Endocrinology 2005 62 521-524. (doi:10.1111/cen.2005.62.issue-5)
86. Sebastian-Ochoa A, Quesada-Charneco M, Fernandez-Garcia D, Reyes-Garcia R, Rozas-Moreno P & Escobar-Jimenez F. Dramatic response to cholestyramine in a patient with Graves' disease resistant to conventional therapy. Thyroid 2008 18 1115-1117. (doi:10.1089/thy.2008.0094)
87. Yang Y, Hwang S, Kim M, Lim Y, Kim MH, Lee S, Lim DJ, Kang MI & Cha BY. Refractory Graves' disease successfully cured by adjunctive cholestyramine and subsequent total thyroidectomy. Endocrinology and Metabolism 2015 30 620-625. (doi:10.3803/EnM.2015.30.4.620)
88. Wenzel KW & Lente JR. Similar effects of thionamide drugs and perchlorate on thyroid-stimulating immunoglobulins in Graves' disease: evidence against an immunosuppressive action of thionamide drugs. Journal of Clinical Endocrinology and Metabolism 1984 58 62-69. (doi:10.1210/jcem-58-1-62)
89. EFSA Panel on Contaminants in the Food Chain. Scientific opinion on the risks to public health related to the presence of perchlorate in food, in particular fruits and vegetables. EFSA Journal 2014 12 3869.
90. Diav-Citrin O, Shechtman S, Tahover E, Finkel-Pekarsky V, Arnon J, Kennedy D, Erebara A, Einarson A & Ornoy A. Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study. American Journal of Psychiatry 2014 171 785-794. (doi:10.1176/appi.ajp.2014.12111402)
91. Laurberg P, Bournaud C, Karmisholt J & Orgiazzi J. Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy. European Journal of Endocrinology 2009 160 1-8. (doi:10.1530/EJE-08-0663)
92. Donnelly MA, Wood C, Casey B, Hobbins J & Barbour LA. Early severe fetal Graves' disease in a mother after thyroid ablation and thyroidectomy. Obstetrics and Gynecology 2015 125 1059-1062. (doi:10.1097/AOG.0000000000000582)
93. McNab T & Ginsberg J. Use of anti-thyroid drugs in euthyroid pregnant women with previous Graves' disease. Clinical and Investigative Medicine 2005 28 127-131.
94. Laurberg P, Nygaard B, Glinoer D, Grussendorf M & Orgiazzi J. Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association. European Journal of Endocrinology 1998 139 584-586.
95. Abeillon-du Payrat J, Chikh K, Bossard N, Bretones P, Gaucherand P, Claris O, Charrie A, Raverot V, Orgiazzi J, Borson-Chazot F et al. Predictive value of maternal second-generation thyroid-binding inhibitory immunoglobulin assay for neonatal autoimmune hyperthyroidism. European Journal of Endocrinology 2014 171 451-460. (doi:10.1530/EJE-14-0254)
96. Besancon A, Beltrand J, Le Gac I, Luton D & Polak M. Management of neonates born to women with Graves' disease: a cohort study. European Journal of Endocrinology 2014 170 855-862. (doi:10.1530/EJE-13-0994)
97. Ide A, Amino N, Kang S, Yoshioka W, Kudo T, Nishihara E, Ito M, Nakamura H & Miyauchi A. Differentiation of postpartum Graves' thyrotoxicosis from postpartum destructive thyrotoxicosis using antithyrotropin receptor antibodies and thyroid blood flow. Thyroid 2014 24 1027-1031. (doi:10.1089/thy.2013.0585)
98. Carlé A, Knudsen N, Pedersen IB, Perrild H, Ovesen L, Rasmussen LB & Laurberg P. Determinants of serum T4 and T3 at the time of diagnosis in nosological types of thyrotoxicosis: a populationbased study. European Journal of Endocrinology 2013 169 537-545. (doi:10.1530/EJE-13-0533)